Quality of reporting of modern randomized controlled trials in medical oncology: A systematic review

Journal of the National Cancer Institute

Volumn 104, Issue 13, 2012, Pages 982-989

  Péron, Julien ^a   Pond, Gregory R ^b   Gan, Hui K ^c   Chen, Eric X ^d   Almufti, Roula ^a   Maillet, Denis ^a   You, Benoit ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b MCMASTER UNIVERSITY   (Canada)

^c AUSTIN HOSPITAL   (Australia)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GEOGRAPHY; HUMAN; INFORMATION PROCESSING; ONCOLOGY; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE; SYSTEMATIC REVIEW; TOTAL QUALITY MANAGEMENT;

GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; INTERNATIONAL COOPERATION; LINEAR MODELS; MEDICAL ONCOLOGY; MULTIVARIATE ANALYSIS; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RESEARCH REPORT; RESEARCH SUPPORT AS TOPIC;

EID: 84863958704     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs259     Document Type: Review

References (33)

1. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926.
2. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352(9128):609-613.
3. Pildal J, Chan AW, Hrobjartsson A, Forfang E, Altman DG, Gotzsche PC. Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. BMJ. 2005;330(7499):1049-1052.
4. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276(8):637-639.
5. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357(9263):1191-1194.
6. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
7. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.BMJ.2010;340:c869.
8. Lai R, Chu R, Fraumeni M, Thabane L. Quality of randomized controlled trials reporting in the primary treatment of brain tumors. J Clin Oncol. 2006;24(7):1136-1144.
9. Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA. 2001;285(15):1992-1995.
10. Toulmonde M, Bellera C, Mathoulin-Pelissier S, Debled M, Bui B, Italiano A. Quality of randomized controlled trials reporting in the treatment of sarcomas. J Clin Oncol. 2001;29(9):1204-1209.
11. Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ. 2010;340:c723.
12. Kober T, Trelle S, Engert A. Reporting of randomized controlled trials in Hodgkin lymphoma in biomedical journals. J Natl Cancer Inst. 2006;98(9):620-625.
13. You B, Gan H, Pond G, Chen XE. Consistency in the analysis and reporting of primary endpoints in oncology randomized controlled trials from registration to publication: a systematic review. J Clin Oncol. 2012;30(2):210-216.
14. Rios LP, Odueyungbo A, Moitri MO, Rahman MO, Thabane, L. Quality of reporting of randomized controlled trials in general endocrinology literature. J Clin Endocrinol Metab. 2008;93(10):3810-3816.
15. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions: Version 5.0.2. Oxford, UK: The Cochrane Collaboration; 2011. http://www.cochrane-handbook.org.
16. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273(5):408-412.
17. Nuesch E, Trelle S, Reichenbach S, et al. The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ. 2009;339:b3244.
18. Wood L, Egger M, Gluud LL, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008;336(7644):601-615.
19. Plint AC, Moher D, Morrison A, et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust. 2006;185(5):263-267.
20. Liberati A, Himel HN, Chalmers TC. A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol. 1986;4(6):942-951.
21. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med. 1997;336(4):309-315.
22. Mills E, Wu P, Gagnier J, Heels-Ansdell D, Montori VM. An analysis of general medical and specialist journals that endorse CONSORT found that reporting was not enforced consistently. J Clin Epidemiol. 2005;58(7):662-667.
23. Djulbegovic B, Lacevic M, Cantor A, et al. The uncertainty principle and industry-sponsored research. Lancet. 2000;356(9230):635-638.
24. Easterbrook PJ, Berlin JA, Gopalan R, Matthews, DR. Publication bias in clinical research. Lancet. 1991;337(8746):867-872.
25. Rochon PA, Gurwitz JH, Simms RW, et al. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med. 1994;154(2):157-163.
26. Devereaux PJ, Choi PT, El-Dika S, et al. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol. 2004;57(12):1232-1236.
27. Huwiler-Muntener K, Juni P, Junker C, Egger M. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA. 2002;287(21):2801-2804.
28. Soares HP, Daniels S, Kumar A, et al. Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group. BMJ. 2004;328(7430):22-24.
29. Jones MN, Mewhort DJ. Representing word meaning and order information in a composite holographic lexicon. Psychol Rev. 2007;114(1):1-37.
30. Haller DG. Providing protocol information for Journal of Clinical Oncology readers: what practicing clinicians need to know. J Clin Oncol. 2011;29(9):1091.
31. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663-694.
32. Devereaux PJ, Manns BJ, Ghali WA, et al. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA. 2001;285(15):2000-2003.
33. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999;319(7211): 670-674.